Abiopharma

🔍 WILSON JAMES N (Executive)

Company: CORCEPT THERAPEUTICS INC (CORT)

Report Date: 2026-03-13

Detailed Transactions and Holdings:

• Sold 28,000 shares of Common Stock (Direct)
  Date: 2026-03-13 | Code: G | equity_swap_involved: false | shares_owned_after: 1,106,532.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-13 | Code: H | nature_of_ownership: James and Pamela Wilson Family Partners | shares_owned_after: 901,067.00 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-13 | Code: H | nature_of_ownership: James N. Wilson 2025 Grantor Retained Annuity Trust. | shares_owned_after: 200,000.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-13 | Code: H | nature_of_ownership: Pamela D. Wilson 2025 Grantor Retained Annuity Trust. | shares_owned_after: 200,000.00

Footnotes:

• F1: Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust and James and Pamela Wilson Family Partners pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.
• REMARKS: The power of attorney under which this form was signed is on file with the Commission.